Direct accesses
Go to main menu
Go to main content
Menu
Search the site
Contact
Careers
You are viewing the website in English
en
fr
Search the site
Who
we are
Company
Leadership
Collaborations
Diseases
we target
Diseases we target
Leber Hereditary Optic Neuropathy (LHON)
Retinitis Pigmentosa (RP)
Geographic Atrophy in Dry-AMD
Our
technologies
Technologies we are applying
Gene Therapy
Mitochondrial Targeting Sequence (MTS)
Optogenetics
Clinical development Summary
Investors
Company Overview
Financial press releases
Investor Newsletters
Events & presentations
Stock information & Financial agenda
Governance
Documentation
Media
Documentation
Home
>
Investors & media
>
Documentation
Year
All
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Documentation type
All
General Assembly
Financial statements and reports
Regulated information
Corporate presentations
General meetings
14 June 2023
Financial statements and reports, General Assembly, General meetings
Supplementary report of the Board of Director dated 23 March 2023
Open in new window
14 June 2023
Financial statements and reports, General Assembly, General meetings
Supplementary report of the Board of Director dated 22 December 2022
Open in new window
10 May 2023
Financial statements and reports
2022 Universal Registration Document
Open in new window
28 July 2022
Financial statements and reports
2022 Half-Year Financial Report
Open in new window
29 April 2022
Financial statements and reports
2021 Universal Registration Document
Open in new window
29 July 2021
Financial statements and reports
2021 Half-Year Financial Report
Open in new window
08 April 2021
Financial statements and reports, General meetings
Auditors’ report on 2020 Consolidated Financial Statements in accordance with IFRS
Open in new window
08 April 2021
Financial statements and reports, General meetings
Auditors’ report on 2020 Financial Statements in accordance with French Gaaps
Open in new window
08 April 2021
Financial statements and reports, General meetings
2020 Universal Registration Document
Open in new window
22 October 2020
Financial statements and reports, Regulated information
Amendment to the 2019 Universal Registration Document
Open in new window
View previous 9 articles
1
2
3
View next 9 articles
Go back to the page of the page